European Ophthalmic Pharmaceuticals Market
European Ophthalmic Pharmaceuticals Market
RELEASE DATE
03-Jul-2010
03-Jul-2010
REGION
Europe
Europe
Research Code: M4AC-01-00-00-00
SKU: HC01830-EU-MR_06733
$4,950.00
In stock
SKU
HC01830-EU-MR_06733
Description
This research service analyses the European ophthalmic pharmaceuticals market. The base year is 2009 with forecasts running through 2016. The segments covered include: the European Glaucoma pharmaceuticals market, European AMD pharmaceuticals market , European Allergic Conjunctivitis pharmaceuticals market , European Diabetic Retinopathy pharmaceuticals market and the European Chronic Dry Eye pharmaceuticals market. It provides the patient forecasts and current treatment options for various ophthalmic diseases. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. In addition, it also provides strategic recommendations.
Table of Contents
Overview
- Overview of the European Ophthalmic Pharmaceuticals Market
Glossary
- Glossary for the Total European Ophthalmic Pharmaceuticals Market
Research Objectives and Scope
- Methodology
- Assumptions and Limitations
Introduction
- Disease Characteristics
Challenges for the Total European Ophthalmic Pharmaceuticals Market
- Key Industry Challenges
Market Engineering Measurements
- Market Engineering Measurements for the Total European Ophthalmic Pharmaceuticals Market
Market Drivers
- Market Drivers for the Total European Ophthalmic Pharmaceuticals Market
Market Restraints
- Market Restraints for the Total European Ophthalmic Pharmaceuticals Market
Revenue Forecasts
Overview
Market Engineering Strategic Recommendations
Databases for Analysis
Popular Topics
This research service analyses the European ophthalmic pharmaceuticals market. The base year is 2009 with forecasts running through 2016. The segments covered include: the European Glaucoma pharmaceuticals market, European AMD pharmaceuticals market , European Allergic Conjunctivitis pharmaceuticals market , European Diabetic Retinopathy pharmaceuticals market and the European Chronic Dry Eye pharmaceuticals market. It provides the patient forecasts and current treatment options for various ophthalmic diseases. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. In addition, it also provides strategic recommendations.
No Index | Yes |
---|---|
Podcast | No |
Author | Ranjith Gopinathan |
Industries | Healthcare |
WIP Number | M4AC-01-00-00-00 |
Is Prebook | No |